-

SYNEOS HEALTH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Syneos Health, Inc. - SYNH

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Syneos Health, Inc. (NasdaqGS: SYNH) to a consortium of affiliates of Elliott Investment Management, Patient Square Capital, and Veritas Capital. Under the terms of the proposed transaction, shareholders of Syneos will receive only $43.00 in cash for each share of Syneos that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgs-synh/ to learn more.

To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

Contacts

Kahn Swick & Foti, LLC
Lewis S. Kahn
855-768-1857
lewis.kahn@ksfcounsel.com

Industry:

Kahn Swick & Foti, LLC

NASDAQ:SYNH
Release Versions
English

Contacts

Kahn Swick & Foti, LLC
Lewis S. Kahn
855-768-1857
lewis.kahn@ksfcounsel.com

More News From Kahn Swick & Foti, LLC

KalVista Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of KalVista Pharmaceuticals, Inc. - KALV

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of KalVista Pharmaceuticals, Inc. (NasdaqGM: KALV) to Chiesi Group. Under the terms of the proposed transaction, shareholders of KalVista will receive $27.00 in cash for each share of KalVista that they own. KSF is seeking to determine whether this consideration and the process that led to it are...

Northfield Bancorp Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Northfield Bancorp, Inc. - NFBK

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Northfield Bancorp, Inc. (NasdaqGS: NFBK) and Columbia Financial, Inc. (NasdaqGS: CLBK). Under the terms of the proposed transaction, each Northfield share will be converted into either stock or cash, at the holder’s election, with consideration tied to the final independent valuation: from 1.425–1.465 holdi...

Thermon Group Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Thermon Group Holdings, Inc. - THR

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Thermon Group Holdings, Inc. (NYSE: THR) to CECO Environmental Corp. (NasdaqGS: CECO). Under the terms of the proposed transaction, shareholders of Thermon may elect to receive, for each share of Thermon common stock, either: (i) $10.00 in cash and 0.6840 shares of CECO common stock, (ii) $63.8...
Back to Newsroom